[{"address1": "170 Harbor Way", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 550 3500", "fax": "650 871 8580", "website": "https://vaxart.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Steven  Lo", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 879327, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sean N. Tucker Ph.D.", "age": 56, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 622439, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James F. Cummings M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 679943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Phillip Eric  Lee", "age": 36, "title": "CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raymond D. Stapleton Jr., Ph.D.", "age": 52, "title": "Chief Technology Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward B. Berg", "age": 59, "title": "Senior VP & General Counsel", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laurie  Hastings", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shaily Jaini Garg", "title": "Senior Vice President of Clinical Development & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Kapoor Ph.D.", "title": "Senior Vice President of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://newsroom.biotapharma.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3887, "open": 0.3913, "dayLow": 0.38, "dayHigh": 0.4191, "regularMarketPreviousClose": 0.3887, "regularMarketOpen": 0.3913, "regularMarketDayLow": 0.38, "regularMarketDayHigh": 0.4191, "exDividendDate": 1352419200, "payoutRatio": 0.0, "beta": 1.279, "forwardPE": -1.0153658, "volume": 708034, "regularMarketVolume": 708034, "averageVolume": 1929831, "averageVolume10days": 1860560, "averageDailyVolume10Day": 1860560, "bid": 0.2917, "ask": 0.4994, "bidSize": 2, "askSize": 2, "marketCap": 95002992, "fiftyTwoWeekLow": 0.28, "fiftyTwoWeekHigh": 1.07, "priceToSalesTrailing12Months": 3.3102088, "fiftyDayAverage": 0.4316, "twoHundredDayAverage": 0.6606, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 60164872, "profitMargins": -2.33268, "floatShares": 226153005, "sharesOutstanding": 228208000, "sharesShort": 13157854, "sharesShortPriorMonth": 12229363, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0577, "heldPercentInsiders": 0.00887, "heldPercentInstitutions": 0.13119, "shortRatio": 6.61, "shortPercentOfFloat": 0.0582, "impliedSharesOutstanding": 228208000, "bookValue": 0.259, "priceToBook": 1.6073359, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -66948000, "trailingEps": -0.33, "forwardEps": -0.41, "lastSplitFactor": "1:11", "lastSplitDate": 1518566400, "enterpriseToRevenue": 2.096, "enterpriseToEbitda": -1.047, "52WeekChange": -0.46575344, "SandP52WeekChange": 0.08001411, "lastDividendValue": 12.188, "lastDividendDate": 1352419200, "quoteType": "EQUITY", "currentPrice": 0.4163, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 51723000, "totalCashPerShare": 0.227, "ebitda": -57443000, "totalDebt": 23284000, "quickRatio": 0.701, "currentRatio": 0.751, "totalRevenue": 28700000, "debtToEquity": 39.515, "revenuePerShare": 0.142, "returnOnAssets": -0.32091, "returnOnEquity": -1.14706, "grossProfits": -45513000, "freeCashflow": 42317248, "operatingCashflow": -44764000, "revenueGrowth": 3.68, "grossMargins": -1.58582, "ebitdaMargins": -2.0015, "operatingMargins": -0.7568, "financialCurrency": "USD", "symbol": "VXRT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "regularMarketChange": 0.02759999, "regularMarketDayRange": "0.38 - 0.4191", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1929831, "fiftyTwoWeekLowChange": 0.1363, "fiftyTwoWeekLowChangePercent": 0.4867857, "fiftyTwoWeekRange": "0.28 - 1.07", "fiftyTwoWeekHighChange": -0.65370005, "fiftyTwoWeekHighChangePercent": -0.6109346, "fiftyTwoWeekChangePercent": -46.575344, "dividendDate": 1518566400, "earningsTimestamp": 1747166400, "earningsTimestampStart": 1747166400, "earningsTimestampEnd": 1747166400, "earningsCallTimestampStart": 1747168200, "earningsCallTimestampEnd": 1747168200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.33, "epsForward": -0.41, "epsCurrentYear": -0.335, "priceEpsCurrentYear": -1.2426865, "fiftyDayAverageChange": -0.015300006, "fiftyDayAverageChangePercent": -0.035449505, "twoHundredDayAverageChange": -0.24430001, "twoHundredDayAverageChangePercent": -0.36981532, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 7.058821, "regularMarketPrice": 0.4163, "longName": "Vaxart, Inc.", "corporateActions": [], "regularMarketTime": 1746723652, "exchange": "NCM", "messageBoardId": "finmb_37819645", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "shortName": "Vaxart, Inc. - Common Stock", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 376929000000, "displayName": "Vaxart", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]